4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001641172-25-017070
Options or other derivatives
- Director acquired 40,565 shares (grant or award)
From the SEC's structured data for this filing
Cardiff Oncology, Inc. Filed Acc 0001641172-25-017070
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…